Form 8-K - Current report:
SEC Accession No. 0001564590-21-004518
Filing Date
2021-02-05
Accepted
2021-02-05 16:31:52
Documents
14
Period of Report
2021-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ABBVIE 8.01 OTHER EVENTS enta-8k_20210205.htm   iXBRL 8-K 39168
2 EX-10.1 enta-ex101_25.htm EX-10.1 1516543
3 EX-10.2 enta-ex102_24.htm EX-10.2 76685
  Complete submission text file 0001564590-21-004518.txt   1954410

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enta-20210205.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210205_lab.xml EX-101.LAB 18714
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210205_pre.xml EX-101.PRE 11169
7 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20210205_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 21596054
SIC: 2834 Pharmaceutical Preparations